The popularity of GLP-1 drugs for weight loss is on the rise, with one in eight adults having taken these medications. However, concerns are raised about the ability of gyms, spas, and other non-medical providers to offer comprehensive obesity care with these drugs. Companies are expanding manufacturing capacity to meet the high demand for GLP-1 drugs, which are also being explored for other indications such as cardiovascular health and sleep apnea. The potential integration of GLP-1 drugs with medical devices is seen as a way to provide holistic obesity care beyond medication. A shift towards whole person care and holistic solutions in the obesity market is advocated for by experts.
Source link
Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush
